MedX Health Corp. MDXHF

0.03 0.00 0.00% as of 24 Sep
Market cap
$103.2M
P/E
0.0×
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
0.00 0.00 0.00 0.00 0.26 0.26 0.01 0.02 0.00 8.75
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
(0.47) (0.47) (0.47) (0.49) (0.40) (1.68) (0.03) (0.15) 0.00 (3.70)
P/B ratio
0.17 0.17 0.17 0.23 1.40 0.20 0.03 0.15 0.00 0.00
Price to Tangible BV
0.27 0.27 0.27 0.36 10.32 0.22 0.00 0.00 0.00 0.00
EV/Sales
0.00 0.00 0.00 0.00 0.24 (0.95) 0.63 0.26 5.93 12.29
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.77 4.33 0.00 0.00 0.00
EV/Operating CF
0.00 0.00 0.00 0.00 (0.13) 0.63 (0.69) (0.86) (1.16) (1.56)
EV/FCF
0.00 0.00 0.00 0.00 (0.13) 0.63 (0.60) (0.62) (0.47) (0.79)
Quick Ratio
3.93 2.80 3.95 2.76 1.51 3.84 1.36 1.71 0.05 0.01
Current Ratio
4.09 3.00 4.17 2.96 1.77 4.05 1.59 1.95 0.10 0.04
Net Debt/EBITDA
2.80 1.48 0.87 0.33 0.04 1.84 (0.66) (0.85) (1.29) (0.40)
Debt/Assets
0.79% 0.00% 0.80% 27.08% 47.44% 19.60% 32.42% 30.81% 346.44% 241.50%
Debt/Equity
0.01 0.02 0.01 0.56 2.58 0.31 4.15 5.52 (0.36) (0.17)
Asset Turnover
0.45 1.28 0.87 0.22 0.48 0.42 0.38 0.57 0.01 0.59
Operating CF/Net income
1.26 0.85 0.89 0.52 0.71 0.78 0.77 0.50 0.69 0.59
Capex/Depreciation
0.00 0.00 0.00 0.00 (0.16) (0.30) (0.57) (0.40) (34.74) (0.04)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(26.03%) (27.25%) (72.01%) (118.02%) (204.65%) (109.96%) (156.70%) (521.70%) (540.15%) 68.26%
ROA
(19.85%) (38.84%) (99.12%) (80.10%) (73.96%) (54.25%) (45.36%) (34.72%) (4.11%) (784.34%)
ROIC
0.00% 0.00% 0.00% 0.00% (338.36%) (538.20%) (77.00%) (69.39%) 0.00% 0.00%
Return on Tangible Assets
(30.52%) (45.47%) (84.37%) (187.95%) (259.55%) (55.94%) (300.40%) (182.67%) 49.04% 66.31%
Average Days of Receivables
237.51 168.69 245.91 207.35 74.56 75.20 92.17 57.66 219.06 97.96
Research and Development Expense of Revenue
4.43% 7.20% 10.93% 21.78% 24.61% 30.01% 20.39% 9.08% 107.47% 105.64%
Selling, General and Administrative Expense of Revenue
99.92% 92.67% 151.56% 261.93% 165.89% 138.19% 130.76% 86.03% 402.63% 789.78%
Intangible Assets out of Total Assets
0.21 0.00 0.24 0.18 0.16 0.05 0.69 0.62 118.58 155.90
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00% 7.02% 5.49% 2.34% 0.95% 28.26% 183.20%
Graham Net Nets
3.17 3.17 3.17 2.24 (0.36) 4.11 (256.07) (76.20) 0.00 (2.42)
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.09
Earnings Yield
(1,143.78%) (1,143.78%) (1,143.78%) (1,143.78%) (1,143.78%) (899.17%) (9,500.00%) (2,850.00%) 0.00% (152.00%)
Free Cash Flow Yield
0.00% 0.00% 0.00% 0.00% (677.37%) (585.61%) (12,294.31%) (2,726.26%) 0.00% (178.45%)
Revenue per Share
0.62 0.87 5.67 2.12 2.22 0.18 2.36 2.70 0.00 0.00
Operating CF per Share
(0.34) (0.22) (5.77) (4.06) (2.43) (0.19) (2.17) (0.83) (0.01) (0.01)
Capex per Share
0.00 0.00 0.00 0.00 (0.06) (0.01) (0.18) (0.11) 0.00 0.00
Free Cash Flow per Share
(0.34) (0.22) (5.77) (4.06) (2.50) (0.19) (2.35) (0.93) (0.01) (0.01)
Cash per Share
0.67 0.34 5.23 3.96 1.92 0.48 0.99 0.86 0.00 0.00
Shareholders Equity per Share
1.14 0.88 10.40 3.54 0.70 0.39 0.59 0.28 (0.02) (0.02)
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
1.14 0.88 10.40 3.54 0.70 0.39 0.59 0.28 (0.02) (0.02)
Free Cash Flow
(15.78) (11.20) (33.26) (25.41) (20.78) (23.44) (36.91) (24.24) (3.02) (2.67)
Working Capital
38.82 26.29 41.82 23.01 10.07 50.17 10.87 18.64 (5.46) (7.00)
Capital Expenditures
(4.65) (5.19) (1.55) (0.08) (0.54) (0.90) (2.79) (2.75) (1.19) 0.00
Net Current Asset Value
36.43 24.42 39.66 11.24 (2.92) 38.43 (80.67) (83.76) (6.25) (7.18)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 46.22 0.00 0.00 0.00
Capex to Sales
0.00 0.00 0.00 0.00 0.03 0.04 0.08 0.04 3.32 0.00
Net Profit Margin
(43.96%) (30.33%) (114.27%) (365.72%) (155.27%) (130.41%) (118.86%) (61.40%) (745.91%) (1,329.23%)
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.62 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.73 0.78 1.42 1.39 3.42 1.82 1.29 1.38 1.19 0.18
Cash ROIC
(21.47%) (22.42%) (39.33%) (47.49%) (57.47%) (20.16%) (59.76%) (38.13%) 48.09% 50.14%
Accounts Receivable Turnover
1.48 2.24 1.55 0.90 3.27 5.32 5.32 6.87 0.06 2.22
Accounts Payable Turnover
1.84 2.18 3.13 3.35 1.91 1.83 2.02 2.77 0.04 0.22
Inventory Turnover
6.58 7.79 8.38 9.98 5.69 5.51 8.42 10.29 0.14 1.84
Average Days of Payables
196.82 168.29 100.23 119.25 186.42 233.07 208.30 122.45 2,945.56 1,700.43
Days of Inventory on Hand
48.15 53.07 45.21 28.67 81.44 59.74 47.62 38.62 465.22 130.17
Average Receivables
19.28 19.28 20.99 14.76 5.65 4.18 6.97 10.22 5.65 0.15
Average Payables
6.07 6.07 5.36 5.09 5.45 6.39 8.82 9.49 5.28 1.75
Average Inventory
1.70 1.70 2.00 1.71 1.83 2.12 2.12 2.55 1.53 0.20
Average Assets
63.15 33.79 37.63 60.45 38.75 53.46 97.10 124.13 64.89 0.57
Average Common Equity
48.16 48.16 51.80 41.03 14.01 26.37 28.11 8.26 0.49 (6.60)

Fold the line items

Columns are period end dates